EFDID: 71256EFD: View Filing

Issuer: Cynapsus Therapeutics Inc. (0001532079) - D/A

Accession: 0001532079-13-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Cynapsus Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    ONTARIO, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    828 RICHMOND STREET WEST
    TORONTO, A6 M6J 1C9
  • Persons:
    Related Persons 9
    Anthony Giovinazzo
    Executive OfficerDirector
    Andrew Williams
    Executive Officer
    Nathan Bryson
    Executive Officer
    Perry Molinoff
    Director
    Julia Levy
    Director
    Ronald Hosking
    Director
    Alan D. C. Ryley
    Director
    Rochelle Stenzler
    Director
    Alan Torrie
    Director
EDGAR: Offering Information
  • Accession Date:
    03/27/2013
  • First Sale Date:
    03/01/2013
  • Offering Amount:
    $13,017,911
  • Amount Sold:
    $4,124,454
  • Amount Remaining:
    $8,893,457
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Each unit it comprised of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of Cdn$0.575 per share for a period of 60 months.
  • Sales Clarification:
    The additional $8,893,457 may be received upon exercise of share purchase warrants sold both inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on March 1, 2013, which was Cdn$1.0285=US$1.00.
EFD: Current State Notices

Notices found in EFD

Filed:None
Inactive:IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Moody Capital Solutions, Inc. 15989 M Partners Inc. None CA
Brookline Group, LLC 153587 M Partners Inc. None AL
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cynapsus Therapeutics Inc./s/ Andrew WilliamsAndrew WilliamsChief Financial Officer and Chief Operations Officer2013-03-25
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Mar. 27, 2013 71256: 0001532079-13-000003 Cynapsus Therapeutics Inc.
Offer Amount: $13,017,911
Amount Sold: $4,124,454
Remaining: $8,893,457
D Mar. 15, 2013 71256: 0001532079-13-000001 Cynapsus Therapeutics Inc.
Offer Amount: $11,225,543
Amount Sold: $3,923,190
Remaining: $7,302,353